{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:19:42Z","timestamp":1791811182180,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.eururo.2011.04.020","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T13:25:32Z","timestamp":1303219532000},"page":"131-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Evaluation of the Methylation Status of Tumour Suppressor Genes for Predicting Bacillus Calmette-Gu\u00e9rin Response in Patients With T1G3 High-Risk Bladder Tumours"],"prefix":"10.1016","volume":"60","author":[{"given":"Miriam","family":"Agundez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Palou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferr\u00e1n","family":"Algaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sanchez-Carbayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2011.04.020_bib0005","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ncpuro0318","article-title":"Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer","volume":"2","author":"Wolff","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.eururo.2011.04.020_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.seminoncol.2006.12.013","article-title":"Molecular alterations associated with bladder cancer progression","volume":"34","author":"Sanchez-Carbayo","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1016\/j.eururo.2011.04.020_bib0015","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","article-title":"CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future","volume":"21","author":"Esteller","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.eururo.2011.04.020_bib0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer","volume":"3","author":"Jones","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.eururo.2011.04.020_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrg1748","article-title":"The epigenetic progenitor origin of human cancer","volume":"7","author":"Feinberg","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.eururo.2011.04.020_bib0030","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.bjc.6604143","article-title":"Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays","volume":"98","author":"Aleman","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2011.04.020_bib0035","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1093\/nar\/gni127","article-title":"Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences","volume":"33","author":"Nygren","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archotol.132.6.668","article-title":"Epigenetic events of disease progression in head and neck squamous cell carcinoma","volume":"132","author":"Worsham","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.eururo.2011.04.020_bib0045","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/labinvest.3700664","article-title":"MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas","volume":"87","author":"Jeuken","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.eururo.2011.04.020_bib0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/07357900802350814","article-title":"Methylation profiles in breast cancer","volume":"27","author":"Buyru","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1016\/j.eururo.2011.04.020_bib0165","doi-asserted-by":"crossref","unstructured":"R\u00f6hrs S, Dirks WG, Meyer C, et al. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 are indicative of MLL translocations in acute myeloid leukemia. Mol Cancer 2009;16;8:86.","DOI":"10.1186\/1476-4598-8-86"},{"key":"10.1016\/j.eururo.2011.04.020_bib0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1479-5876-8-86","article-title":"Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer","volume":"8","author":"Castro","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.eururo.2011.04.020_bib0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.04.020_bib0070","series-title":"Basic and clinical biostatistics","author":"Dawson-Saunders","year":"1994"},{"key":"10.1016\/j.eururo.2011.04.020_bib0075","first-page":"2473","article-title":"Progressive increases in de novo methylation of CpG islands in bladder cancer","volume":"60","author":"Salem","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0080","first-page":"8659","article-title":"Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features","volume":"61","author":"Maruyama","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0085","first-page":"4048","article-title":"The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers","volume":"62","author":"Tada","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0090","first-page":"464","article-title":"Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients","volume":"8","author":"Chan","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0095","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.ejca.2005.07.019","article-title":"Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma","volume":"41","author":"Friedrich","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2011.04.020_bib0100","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1158\/1078-0432.CCR-03-0127","article-title":"Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel","volume":"10","author":"Dulaimi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0105","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","article-title":"Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma","volume":"23","author":"Catto","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.04.020_bib0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mrfmmm.2006.03.002","article-title":"Methylation and repeats in silent and nonsense mutations of p53","volume":"599","author":"Kouidou","year":"2006","journal-title":"Mutat Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0115","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bbrc.2005.11.072","article-title":"p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer","volume":"339","author":"Kawamoto","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.eururo.2011.04.020_bib0120","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jnci\/djj265","article-title":"Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection","volume":"98","author":"Hoque","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2011.04.020_bib0125","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.1991","article-title":"Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma","volume":"209","author":"Dhawan","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.eururo.2011.04.020_bib0130","first-page":"547","article-title":"Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas","volume":"18","author":"Kunze","year":"2006","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.eururo.2011.04.020_bib0135","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1158\/1078-0432.CCR-06-2476","article-title":"Promoter hypermethylation identifies progression risk in bladder cancer","volume":"13","author":"Yates","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0140","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1158\/1078-0432.CCR-07-0861","article-title":"A novel set of DNA methylation markers in urine sediments for sensitive\/specific detection of bladder cancer","volume":"13","author":"Yu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2407-8-238","article-title":"DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection","volume":"8","author":"Negraes","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2011.04.020_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000158665","article-title":"Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer","volume":"75","author":"Jarmalaite","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.eururo.2011.04.020_bib0155","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1158\/0008-5472.CAN-10-1335","article-title":"Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue","volume":"70","author":"Wolff","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2011.04.020_bib0160","doi-asserted-by":"crossref","first-page":"e12334","DOI":"10.1371\/journal.pone.0012334","article-title":"Identification of methylated genes associated with aggressive bladder cancer","volume":"5","author":"Marsit","year":"2010","journal-title":"PLoS One"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811003885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811003885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:02:13Z","timestamp":1759582933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283811003885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0302283811003885"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2011.04.020","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Methylation Status of Tumour Suppressor Genes for Predicting Bacillus Calmette-Gu\u00e9rin Response in Patients With T1G3 High-Risk Bladder Tumours","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2011.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}